Compare ONEW & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONEW | BNTC |
|---|---|---|
| Founded | 2014 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.3M | 344.4M |
| IPO Year | 2019 | 2020 |
| Metric | ONEW | BNTC |
|---|---|---|
| Price | $9.32 | $9.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | $13.00 | ★ $23.29 |
| AVG Volume (30 Days) | 101.1K | ★ 179.5K |
| Earning Date | 11-17-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.67 |
| EPS | ★ 2.77 | N/A |
| Revenue | ★ $1,872,334,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.86 | N/A |
| P/E Ratio | $3.55 | ★ N/A |
| Revenue Growth | ★ 5.62 | N/A |
| 52 Week Low | $8.12 | $7.89 |
| 52 Week High | $15.25 | $14.39 |
| Indicator | ONEW | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 43.72 | 48.02 |
| Support Level | $8.83 | $8.14 |
| Resistance Level | $10.12 | $9.29 |
| Average True Range (ATR) | 0.75 | 0.67 |
| MACD | -0.00 | 0.12 |
| Stochastic Oscillator | 15.81 | 47.97 |
OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.